U.S. health authorities now recommend that girls and young women be vaccinated against human papillomavirus, a sexually transmitted disease that is a known cause of cervical cancer, but that recommendation does not extend to...
Dr. Ramona Kwapiszewski is a family practice physician at Muskegon Family Care's Getty Street Clinic. She has specialty training in blood testing to diagnose allergies.
OXFORD, England, September 27, 2011 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced positive phase II clinical results showing that its ToleroMuneĀ® hay fever vaccine substantially improved patients
Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with Gregorio Mara--n Hospital in Madrid and Cl-nic Hospital in Barcelona, reveals MVA-B preventive vaccine's immune efficiency against Human's immunodeficie
According to today's announcement made by Circassia Ltd, a specialty biopharmaceutical company focused on allergy, ToleroMune'sĀ® positive phase II clinical trials showed that the hay fever vaccine treatment was extremely well tolerated and substantially